Cannabis Report
Home > Boards > US OTC > Biotechs > NorthWest Biotherapeutics Inc. (NWBO)

My point is that since About July of

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
flipper44 Member Profile
Member Level 
Followed By 78
Posts 14,021
Boards Moderated 0
Alias Born 11/14/13
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 9/13/2018 4:24:26 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/14/2018 4:52:44 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/28/2018 5:23:29 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/28/2018 4:12:19 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/18/2018 5:16:53 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/1/2018 4:34:18 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/31/2018 5:01:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/31/2018 7:03:23 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/21/2018 4:44:29 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/16/2018 5:06:32 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 5/16/2018 4:42:32 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/7/2018 5:26:40 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/2/2018 3:52:43 PM
Traders News Source Issues Research Reports on ANDI, FUSZ, RNVA and NWBO InvestorsHub NewsWire - 4/19/2018 8:00:00 AM
Annual Report (10-k) Edgar (US Regulatory) - 4/17/2018 5:11:43 PM
Revised Proxy Soliciting Materials (definitive) (defr14a) Edgar (US Regulatory) - 4/12/2018 5:26:20 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/9/2018 4:15:48 PM
Proxy Soliciting Materials (revised) (prer14a) Edgar (US Regulatory) - 4/4/2018 5:19:57 PM
Notification That Annual Report Will Be Submitted Late (nt 10-k) Edgar (US Regulatory) - 4/3/2018 6:07:43 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 3/26/2018 5:18:11 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 3/26/2018 5:12:56 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/22/2018 4:41:41 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/20/2018 5:11:43 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/15/2018 5:21:44 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/7/2018 4:06:26 PM
flipper44 Member Level  Friday, 01/12/18 03:44:05 PM
Re: SheemaGato post# 153161
Post # of 190509 
My point is that since About July of 2015 I've been watching Cognate hiring. Installation of clean rooms for Cognate and advent at same time by same manufacturer. I've watched NWBO add language to their last 10q that they are currently working on expanding for DCVax-l production in UK and Europe in addition to currently negotiating said contracts. I am following NICE and paying attention to how that timing indicates possibility of earlier approval back home in the U.S. I'm watching the fact that the public should be receiving a DCVax-l publication any day. I'm watching guidances that may help DCVax-l early AA if they were successful.

Sure, Cognate might be expanding for somebody else, but I'd lean toward their primary expansion being for DCVax-l.


Respect Risk. Conduct Your Own Due Diligence. Manage your assets wisely. Diversify.
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist